Moderna’s mRNA HIV Vaccine Starts Phase I Trial
Could we be on the brink of a cure for AIDS? That is what many are asking after news broke that Moderna Therapeutics has started a phase I trial testing their mRNA HIV vaccine. The vaccine was developed using a new technology that encodes pieces of genetic code into messenger RNA molecules. These molecules can be injected directly into cells, where they produce proteins that can help fight disease. If this vaccine is successful, it could be life-saving for the millions of people living with HIV/AIDS.
This is not the first time that Moderna Therapeutics has made headlines with their work on a potential HIV vaccine. They announced that they were working on a vaccine that uses DNA instead of mRNA earlier this year. This vaccine is still in the early stages of development, but it has shown promise in animal trials.
The medical community is hopeful that these vaccines will help eradicate a disease plaguing humanity since 1981. There have been many attempts at developing an effective vaccine against HIV/AIDS, but none have succeeded so far due in part to the virus’s ability to mutate rapidly.
It is still too early to know whether either of these vaccines will be successful, but the potential they hold is very exciting for researchers in the field. It is important to remember that there are currently no cures for AIDS, but we may be on the brink of a breakthrough. We will have to wait and see what the future holds.
Photo by RF._.studio from Pexels